Health & Nutrition

bg
The 4 key things we're watching in the stock market this holiday-shortened week

The 4 key things we're watching in the stock market this...

With earnings season just about down, our attention turns to economic data for signs...

bg
Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut

Google-backed Tempus AI closes first day of trading up...

Tempus AI rose by as much as 15% on Friday after the health-care diagnostics company...

bg
Here are 9 stocks that can benefit from Fed interest rate cuts

Here are 9 stocks that can benefit from Fed interest rate...

While lower borrowing costs would likely benefit the overall market, several names...

bg
Healthy Returns: What we know about the next round of Covid vaccines

Healthy Returns: What we know about the next round of Covid...

A new round of Covid shots is coming. Meanwhile, the White House is partnering with...

bg
Headache and Migraine Relief from Foods 

Headache and Migraine Relief from Foods 

Plant-based diets are put to the test for treating migraine headaches. Headaches...

bg
Weight loss boom is spurring sales of protein, meal replacement products, Vitamin Shoppe CEO says

Weight loss boom is spurring sales of protein, meal replacement...

Companies like The Vitamin Shoppe are leaning into protein and other supplements...

bg
Roche alleges counterfeit diabetes medical devices were sold on Amazon

Roche alleges counterfeit diabetes medical devices were...

Counterfeit diabetes test strips have been sold on Amazon and shipped to patients...

bg
FDA approves two new Abbott over-the-counter continuous glucose monitors

FDA approves two new Abbott over-the-counter continuous...

Abbott has FDA clearance for two new over-the-counter continuous glucose monitoring...

bg
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial

Moderna's combination Covid, flu vaccine is more effective...

Moderna is the first company to release positive phase three data on a Covid and...

bg
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval

FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab,...

If approved, Eli Lilly's donanemab would become the second Alzheimer's drug of its...